Latest Shareholder Approval News

EQ Resources Limited has successfully raised $34 million through a share placement, aiming to accelerate development at its Carbine Vein project and strengthen its balance sheet amid robust tungsten market conditions.

AusQuest Limited has raised A$10 million through a share placement to expand drilling at its promising Cangallo copper-gold project in Peru, aiming to unlock higher-grade mineralisation.

Arika Resources has secured $5.7 million through a heavily oversubscribed placement to accelerate drilling at its Yundamindra and Kookynie gold projects in Western Australia, with directors committing $0.65 million themselves.

Prospech Limited has launched a 1,600-metre diamond drilling campaign at its Korsnäs rare earth element project in Finland, supported by promising passive seismic survey results that highlight potential new mineralised zones.

Premier Investments Limited has announced an on-market share buy-back program valued up to $100 million AUD, set to commence in late December 2025 and run through 2026.

Forrestania Resources has launched a conditional all-scrip takeover offer for Kula Gold, valuing the company at approximately $42.7 million. The Kula board unanimously recommends acceptance, highlighting strategic regional consolidation and operational synergies.

New Frontier Minerals has completed a $2.25 million placement to professional investors, issuing over 107 million shares and promising additional attaching options early next year. This capital injection aims to accelerate exploration at its key projects in the Northern Territory and Queensland.

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

L1 Global Long Short Fund Limited has successfully completed its shortfall offer bookbuild, prompting a $62 million institutional placement at $1.63 per share, adding to a total raise of up to $415 million. Trading is set to resume immediately following the announcement.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

Greenvale Energy has raised approximately AUD 856,000 through an oversubscribed Share Purchase Plan, strengthening its uranium exploration efforts in Queensland and the Northern Territory.